Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Antimicrobial Therapeutics Market: By Application: Antiviral, Antibacterial, Antifungal, Antiparasitic; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; SWOT Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Antimicrobial Therapeutics Market Outlook

The global antimicrobial therapeutics market will grow at a CAGR of 5% during the 2021-2026 forecast period. The rising prevalence of deadly diseases such as HIV and HPV has created the need for high-quality diagnostics that will make it possible to detect the infection early.

 

Global Antimicrobial Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

The antimicrobial therapy destroys micro-organisms such as bacteria, fungi, or protozoans, or inhibits their growth. Microbiocidal therapies and treatments that inhibit the growth of micro-organisms or kill the micro-organisms are called microbiocidal therapies. The antimicrobial therapeutics market can be divided based on segments like application. The antimicrobial therapeutics market can be broadly categorised based on application into:

 

Global Antimicrobial Therapeutics Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiparasitic

The EMR report looks into the regional antimicrobial therapeutics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Antimicrobial Therapeutics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Technological advances in the healthcare industry have helped to develop sophisticated methods of diagnosis and diagnostic point-of-care (PoC) tests. Several companies are focussing on developing PoC products such as lab-based viral load technologies and simple PoC tests that minimize diagnostic time and provide high patient compliance. Before the onset of the disease, biomarkers and innovative diagnostics are also being developed to manage the disease better and formulate a strategy. Increasing the modalities for diagnosing infection will be one of the key industry trends for antimicrobial therapy that will have a positive impact on the antimicrobial therapeutics market growth. Together with recent drug approvals, the existence of a strong pipeline will fuel antimicrobial therapeutics market growth.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global antimicrobial therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Gilead Sciences, Inc. (NASDAQ: GILD)
  • GlaxoSmithKline plc 
  • Merck & Co Inc. 
  • Pfizer Inc. 
  • Sanofi 
  • Others 

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

Key Questions Answered in the Market Report

  • How has the global antimicrobial therapeutics market performed in the previous years (2016-2020)?
  • What is the forecast assessment of the antimicrobial therapeutics market for 2021-2026?
  • What are the major drivers of the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major constraints of the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major demand indicators of the global antimicrobial therapeutics market?
  • What are the import and export trends in the global antimicrobial therapeutics market?
  • Who are the top importers and exporters of antimicrobial therapeutics in the industry globally?
  • Who are the key manufacturers in the global antimicrobial therapeutics market?
  • What is the degree of competition in the global antimicrobial therapeutics market?
  • What are the major events and developments taking place within the global industry?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6     Global Antimicrobial Therapeutics Market Analysis
    6.1    Global Antimicrobial Therapeutics Historical Market (2016-2020) & Forecast (2021-2026)
    6.2    Global Antimicrobial Therapeutics Market Breakup by Application
        6.2.1    Antiviral
        6.2.2    Antibacterial
        6.2.3    Antifungal
        6.2.4    Antiparasitic
    6.3    Global Antimicrobial Therapeutics Market Breakup by Application: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Antiviral
        6.3.2    Antibacterial
        6.3.3    Antifungal
        6.3.4    Antiparasitic
    6.4    Global Antimicrobial Therapeutics Market Breakup by Region
        6.4.1    North America
            6.4.1.1    United States of America
            6.4.1.2    Canada
        6.4.2    Europe
            6.4.2.1    Germany
            6.4.2.2    United Kingdom
            6.4.2.3    France
            6.4.2.4    Italy
            6.4.2.5    Others
        6.4.3    Asia Pacific
            6.4.3.1    China
            6.4.3.2    Japan
            6.4.3.3    India
            6.4.3.4    ASEAN
            6.4.3.5    Others
        6.4.4    Latin America
            6.4.4.1    Brazil
            6.4.4.2    Argentina
            6.4.4.3    Mexico
            6.4.4.4    Others
        6.4.5    Middle East & Africa
            6.4.5.1    Saudi Arabia
            6.4.5.2    United Arab Emirates
            6.4.5.3    Nigeria
            6.4.5.4    South Africa
            6.4.5.5    Others
    6.5     Global Antimicrobial Therapeutics Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    North America
            6.5.1.1    United States of America
            6.5.1.2    Canada
        6.5.2    Europe
            6.5.2.1    Germany
            6.5.2.2    United Kingdom
            6.5.2.3    France
            6.5.2.4    Italy
            6.5.2.5    Others
        6.5.3    Asia Pacific
            6.5.3.1    China
            6.5.3.2    Japan
            6.5.3.3    India
            6.5.3.4    ASEAN
            6.5.3.5    Others
        6.5.4    Latin America
            6.5.4.1    Brazil
            6.5.4.2    Argentina
            6.5.4.3    Mexico
            6.5.4.4    Others
        6.5.5    Middle East & Africa
            6.5.5.1    Saudi Arabia
            6.5.5.2    United Arab Emirates
            6.5.5.3    Nigeria
            6.5.5.4    South Africa
            6.5.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis   
    9.1    Gilead Sciences, Inc. (NASDAQ: GILD)
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    GlaxoSmithKline plc ( LON: GSK )
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Merck & Co Inc. (NYSE: MRK)
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Pfizer Inc. (PFE :NYSE)
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Sanofi (EPA: SAN)
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Others
10    Industry Events and Developments 

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER